PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE INCREASINGLY SHIFTING THEIR DRUG DEVELOPMENT

Research and Markets has announced the addition of the Decision Resources report "Emerging Antiviral Drug Targets" to their offering In recent years, many pharmaceutical and biotechnology companies have shifted their drug development for infectious diseases from antibacterial to antiviral discovery and development. This trend reflects a perception among many companies of limited commercial opportunity in antibacterials - due to high competition, increased genericization, and short treatment courses.
Business Wire